Abstract: The present invention relates to solid pharmaceutical dosage forms suitable for use as drinking water medication. More in particular, the present invention provides solid pharmaceutical dosage forms comprising a pharmaceutically active agent, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8, and a maltodextrin. The present invention also provides the use of such pharmaceutical dosage forms in veterinary medicine, more in particular as drinking water medication; as well as methods for preparing such pharmaceutical dosage forms.
Type:
Grant
Filed:
February 17, 2016
Date of Patent:
July 2, 2019
Assignees:
Universiteit Gent, Orotech NV
Inventors:
Jean-Paul Remon, Chris Vervaet, Brenda Vermeulen
Abstract: The present invention relates to solid pharmaceutical dosage forms suitable for use as drinking water medication. More in particular, the present invention provides solid pharmaceutical dosage forms comprising a pharmaceutically active agent, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8, and a maltodextrin. The present invention also provides the use of such pharmaceutical dosage forms in veterinary medicine, more in particular as drinking water medication; as well as methods for preparing such pharmaceutical dosage forms.
Type:
Application
Filed:
February 17, 2016
Publication date:
March 8, 2018
Applicants:
Universiteit Gent, Orotech NV
Inventors:
Jean-Paul Remon, Chris Vervaet, Brenda Vermeulen